JPH01110366A - Artificial tubal organ - Google Patents
Artificial tubal organInfo
- Publication number
- JPH01110366A JPH01110366A JP62268124A JP26812487A JPH01110366A JP H01110366 A JPH01110366 A JP H01110366A JP 62268124 A JP62268124 A JP 62268124A JP 26812487 A JP26812487 A JP 26812487A JP H01110366 A JPH01110366 A JP H01110366A
- Authority
- JP
- Japan
- Prior art keywords
- artificial
- layer
- bio
- recess
- organ
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000000056 organ Anatomy 0.000 title claims abstract description 12
- 102000008186 Collagen Human genes 0.000 claims abstract description 15
- 108010035532 Collagen Proteins 0.000 claims abstract description 15
- 229920001436 collagen Polymers 0.000 claims abstract description 15
- 239000000463 material Substances 0.000 claims abstract description 14
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims abstract description 12
- 239000001506 calcium phosphate Substances 0.000 claims abstract description 8
- 229910000389 calcium phosphate Inorganic materials 0.000 claims abstract description 7
- 235000011010 calcium phosphates Nutrition 0.000 claims abstract description 7
- 239000002241 glass-ceramic Substances 0.000 abstract description 10
- 229910052586 apatite Inorganic materials 0.000 abstract description 7
- VSIIXMUUUJUKCM-UHFFFAOYSA-D pentacalcium;fluoride;triphosphate Chemical compound [F-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O VSIIXMUUUJUKCM-UHFFFAOYSA-D 0.000 abstract description 7
- 239000000835 fiber Substances 0.000 abstract description 6
- 239000007921 spray Substances 0.000 abstract description 3
- 238000003466 welding Methods 0.000 abstract description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 abstract 2
- DLYUQMMRRRQYAE-UHFFFAOYSA-N tetraphosphorus decaoxide Chemical compound O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 abstract 2
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 abstract 1
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 abstract 1
- 229910052681 coesite Inorganic materials 0.000 abstract 1
- 229910052593 corundum Inorganic materials 0.000 abstract 1
- 229910052906 cristobalite Inorganic materials 0.000 abstract 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000000377 silicon dioxide Substances 0.000 abstract 1
- 235000012239 silicon dioxide Nutrition 0.000 abstract 1
- 229910052682 stishovite Inorganic materials 0.000 abstract 1
- 229910000391 tricalcium phosphate Inorganic materials 0.000 abstract 1
- 235000019731 tricalcium phosphate Nutrition 0.000 abstract 1
- 229940078499 tricalcium phosphate Drugs 0.000 abstract 1
- 229910052905 tridymite Inorganic materials 0.000 abstract 1
- 229910001845 yogo sapphire Inorganic materials 0.000 abstract 1
- 210000003437 trachea Anatomy 0.000 description 21
- 210000001519 tissue Anatomy 0.000 description 13
- 239000000758 substrate Substances 0.000 description 8
- 210000003238 esophagus Anatomy 0.000 description 6
- 239000013078 crystal Substances 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 239000004677 Nylon Substances 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 230000005856 abnormality Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000001072 colon Anatomy 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- -1 polyethylene Polymers 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 230000003248 secreting effect Effects 0.000 description 2
- 229920002379 silicone rubber Polymers 0.000 description 2
- 239000004945 silicone rubber Substances 0.000 description 2
- 230000000087 stabilizing effect Effects 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 210000000115 thoracic cavity Anatomy 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 229920000339 Marlex Polymers 0.000 description 1
- 208000003898 Mediastinal Emphysema Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 206010050184 Pneumomediastinum Diseases 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 238000002441 X-ray diffraction Methods 0.000 description 1
- 239000012237 artificial material Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001886 ciliary effect Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000013256 coordination polymer Substances 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 230000008260 defense mechanism Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000010304 firing Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000006112 glass ceramic composition Substances 0.000 description 1
- 230000009442 healing mechanism Effects 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 210000001630 jejunum Anatomy 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920000137 polyphosphoric acid Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000002271 resection Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229920000260 silastic Polymers 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 210000005062 tracheal ring Anatomy 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Materials For Medical Uses (AREA)
Abstract
Description
【発明の詳細な説明】
〔産業上の利用分野〕
本発明は、人工気管、人工食道などの人工管腔臓器に関
するものである。DETAILED DESCRIPTION OF THE INVENTION [Industrial Field of Application] The present invention relates to artificial lumen organs such as an artificial trachea and an artificial esophagus.
人工気管は、テフロン(商品名)、マーレックスメツシ
ュ(商品名)、シラスティックチューブ(商品名)、ス
テンレスなどを素材として用いるノンポーラスのチュー
ブ方式はガラス管、ビニール管、ナイロン管が提案され
たが管の変形、滑脱などのためよい結果が得られなかっ
た、その後シリコンラバーポリエチレン管に銅線による
滑り止めを施したものを用いて良い結果を得ている。上
皮再生を図るためのメツシュ方式は、ステンレススチー
ルワイヤーメツシュ、ナイロンメツシュ、サランポリエ
チレンメツシュなどの提案が行なわれている。Artificial tracheas are made of materials such as Teflon (trade name), Marlex mesh (trade name), Silastic tube (trade name), and stainless steel. Glass tubes, vinyl tubes, and nylon tubes are proposed as nonporous tubes. Good results were not obtained due to deformation and slippage of the hoop tube, but good results were subsequently obtained by using a silicone rubber polyethylene tube with a non-slip layer made of copper wire. As mesh methods for epithelial regeneration, proposals have been made such as stainless steel wire mesh, nylon mesh, and saran polyethylene mesh.
人工食道については、頚部食道切除後の再建には胃、結
腸、皮膚管などを移植して用いられており、胸部食道切
除後の再建には胃、結腸、ときには小腸が用いられ、下
部食道噴量切除後の再建には空腸、胃が用いられている
。Regarding artificial esophagus, the stomach, colon, skin tube, etc. are transplanted for reconstruction after cervical esophagectomy, and the stomach, colon, and sometimes the small intestine are used for reconstruction after thoracic esophagectomy. The jejunum and stomach are used for reconstruction after volume resection.
ところで人工気管には次のような条件が課せられる。■
完全な気密性がなければならない。気管は空気の通り道
であるから素材からの空気もれがあってはならないから
である。特に胸腔内は除圧状態であるので、わずかな孔
でも多量の空気がもれて縦隔気腫の状態となり致命的と
なる。■素材に一定の支持力をもたせて内腔を保つ必要
がある。By the way, the following conditions are imposed on the artificial trachea. ■
Must be completely airtight. This is because the trachea is a passageway for air, so there must be no air leakage from the material. In particular, because the pressure inside the thoracic cavity is decompressed, even the slightest hole can cause a large amount of air to leak, resulting in pneumomediastinum, which can be fatal. ■It is necessary to maintain the inner cavity by giving the material a certain amount of support.
■気管壁には気道の防禦機構として多くの分泌腺があり
、多量の分泌液が繊毛運動によって流れているので、素
材がこの流れを妨げてはならない。■The tracheal wall has many secretory glands that serve as a defense mechanism for the airways, and a large amount of secretory fluid flows through ciliary movement, so the material must not impede this flow.
■素材が十分な組織親和性を有していないと、気管壁に
とりこまれて安定かすることが困難である。■If the material does not have sufficient tissue affinity, it will be difficult to incorporate it into the tracheal wall and stabilize it.
皮膚と同様に外界に面している部分では、異物である人
工素材を用いると異物を外界に排除しようとする治癒機
転が働く。Like the skin, when artificial materials that are foreign substances are used in areas that face the outside world, a healing mechanism works to remove the foreign substances to the outside world.
しかしながら、従来の素材を用いた人工気管は前記条件
のうちの一つ或いはそれ以上を欠いていた。特に前記条
件■の組織親和性については従来の素材ではほとんど充
足できなかった。However, artificial tracheas using conventional materials lack one or more of the above requirements. In particular, the above-mentioned condition (1), tissue compatibility, could hardly be satisfied with conventional materials.
さらに従来の素材は耐熱性が余り良くないので、数百度
以上の乾熱滅菌ができない欠点もあった。Furthermore, conventional materials have poor heat resistance, so they cannot be sterilized using dry heat at temperatures above several hundred degrees.
本発明はこうした欠点を解消すべくなされたもので、上
記の条件を満足し、特に生体組織となじみやすい人工管
腔臓器を提供することを目的としたものである。The present invention has been made to eliminate these drawbacks, and aims to provide an artificial hollow organ that satisfies the above conditions and is particularly compatible with living tissue.
本発明の人工管腔臓器は、上記目的を達成するため組織
親和性を有する稠密な材料からなる中空の基体の表面に
組織親和性を有するコラーゲン繊維を被覆したものであ
る。In order to achieve the above object, the artificial hollow organ of the present invention is one in which the surface of a hollow base body made of a dense material having tissue affinity is coated with collagen fibers having tissue affinity.
このような本発明の人工管腔臓器においては、基体その
ものが組織親和性を有していないとともにその外側に被
覆したコラーゲンが強い生体親和力を有しているため、
生体と接した場合、きわめて大きな組繊親和性により生
体との安定化を実現できる。また基体は稠密構造を有し
ているので気密性が保たれることになる。In such an artificial hollow organ of the present invention, the base itself does not have tissue affinity, and the collagen coated on the outside has strong biocompatibility.
When it comes into contact with living organisms, it can be stabilized with living organisms due to its extremely high affinity for fibers. Furthermore, since the base has a dense structure, airtightness is maintained.
第1図は本発明による人工管腔臓器の一実施例を示すも
のであり、本例では人工気管として構成したものである
。人工気管1の基体は稠密構造を有するガラスセラミッ
クスより成る中空管状の本体2、このガラスセラミック
ス本体を加熱することによりその表面に析出して形成し
た組織親和性を有するアパタイト層3およびその表面に
焼成形成した組織親和性を有するβ−T CP (Tr
icalciumPhosphate: Caz(PO
<)z)層4を以って構成し、この基体の表面上にコラ
ーゲン繊維層5を被覆する。FIG. 1 shows an embodiment of an artificial lumen organ according to the present invention, and in this example, it is constructed as an artificial trachea. The base of the artificial trachea 1 is a hollow tubular main body 2 made of glass ceramic with a dense structure, an apatite layer 3 having tissue affinity deposited on the surface by heating the glass ceramic main body, and an apatite layer 3 having a tissue affinity formed on the surface. β-T CP (Tr
icalciumPhosphate: Caz(PO
<)z) Consisting of a layer 4, a collagen fiber layer 5 is coated on the surface of this substrate.
人工気管1の3本の枝路の先端にはリング6を設けであ
るが、このリングも組織讐相性を有する基体の表面に繊
維状のコラーゲン層を被覆して構成する。このようなリ
ング6は人工気管lを体内に留置する際に有用である。A ring 6 is provided at the tips of the three branches of the artificial trachea 1, and this ring is also constructed by covering the surface of a tissue-compatible substrate with a fibrous collagen layer. Such a ring 6 is useful when the artificial trachea l is placed in the body.
上述したように、本例では組織親和性の高い基体2.3
.4の表面に同じく組織親和性の高い繊維状のコラーゲ
ン層5を被覆したため、人工気管1としての組織親和性
は著しく高くなり、体内に安定して保持されることにな
る。また本体2は人工骨と同様の稠密さを有するガラス
セラミックスで構成しであるため、十分な気密性が得ら
れるとともに機械的強度も高く、加工性も良好となる。As mentioned above, in this example, the substrate 2.3 with high tissue affinity is used.
.. Since the surface of the artificial trachea 4 is coated with a fibrous collagen layer 5 which also has high tissue affinity, the tissue affinity of the artificial trachea 1 is significantly increased, and it is stably retained in the body. Furthermore, since the main body 2 is made of glass ceramic having the same density as artificial bone, sufficient airtightness is obtained, mechanical strength is high, and workability is also good.
さらに、ガラスセラミックス本体2は耐熱性にも富んで
いるので、高温殺菌が可能となる。Furthermore, since the glass ceramic body 2 has high heat resistance, high temperature sterilization is possible.
次に、このような人工管lの製造工程を第2図〜第7図
を参照して説明する。先ず第2図に示すような中空の本
体2を準備する。この本体2は熱処理によりリン酸カル
シウム結晶が表面に析出するようなガラスセラミックス
材料を以って構成する。このガラスセラミックスはCa
b、 Pz05* MgO+A j! toz、 Si
ngなどから構成され、850℃以上で熱処理し、X線
回折をしてみるとアバフィト結晶が析出していることが
確認される。第7図は熱処理後の表面構造を示す拡大断
面図であり、ガラスセラミックスより成る本体2の外表
面には微小の凹凸が形成され、表面にアパタイト結晶層
3が析出している。Next, the manufacturing process of such an artificial tube 1 will be explained with reference to FIGS. 2 to 7. First, a hollow main body 2 as shown in FIG. 2 is prepared. The main body 2 is made of a glass ceramic material on which calcium phosphate crystals are deposited on the surface by heat treatment. This glass ceramic is Ca
b, Pz05* MgO+A j! toz, Si
When heat-treated at 850° C. or higher and subjected to X-ray diffraction, it was confirmed that abaphyte crystals were precipitated. FIG. 7 is an enlarged cross-sectional view showing the surface structure after heat treatment, in which minute irregularities are formed on the outer surface of the main body 2 made of glass ceramics, and an apatite crystal layer 3 is deposited on the surface.
次に第3図に示すように中間部26を熱的、機械的に削
除し、反対側を酸水素炎バーナで加熱して曲げ第4図に
示すごとく同じ構造を有する別の短い本体2bを溶着さ
せ第5図に示すごとき形状にする。Next, as shown in FIG. 3, the intermediate portion 26 is removed thermally and mechanically, and the opposite side is heated with an oxyhydrogen flame burner and bent to form another short body 2b having the same structure as shown in FIG. Weld it to the shape shown in Figure 5.
溶着後、全体を熱処理して本体2,2bの表面にリン酸
カルシウム(アパタイト)結晶層3を析出させる。この
ようにして析出形成したアパタイトN3の表面にさらに
β−TCP ()リカルシウムフォスフェート)層4を
スプレーコートし、750°C以上の高温度で焼成結合
した状態を第6図に示す。実験においてはβ−TCP粉
末をポリアクリル酸アンモニウム塩及び水により乳液化
したものをスプレーガンでコートし、800度で2時間
焼成したところよい結果が得られた。After welding, the entire body is heat-treated to deposit a calcium phosphate (apatite) crystal layer 3 on the surfaces of the bodies 2, 2b. FIG. 6 shows the state in which a β-TCP (recalcium phosphate) layer 4 was further spray-coated on the surface of the apatite N3 precipitated in this manner and bonded by firing at a high temperature of 750° C. or higher. In the experiment, good results were obtained when β-TCP powder was emulsified with ammonium polyacrylate salt and water, coated with a spray gun, and baked at 800 degrees for 2 hours.
このようにして構成された基体の表面を繊維状コラーゲ
ン層5などで被覆する。実験においては7%ポリリン酸
の希薄液とともにコラーゲンを被覆したところよい結果
が得られた。The surface of the base thus constructed is covered with a fibrous collagen layer 5 or the like. In experiments, good results were obtained when collagen was coated with a dilute solution of 7% polyphosphoric acid.
このようにして構成した後、生体気管と結合するための
リング6を人工気管lの各枝先端に付設する。これは枝
先端上に生体気管を被せた後、縛りつけた際に係止部と
なるように或いはリング表面を滑り止め形成した場合に
は縛りつけ個所とするためのものである。表面にコラー
ゲンを付着固定しておくことはいうまでもない。After having been constructed in this way, a ring 6 for coupling with the biological trachea is attached to each branch tip of the artificial trachea l. This is to serve as a locking part when the biological trachea is placed over the tip of the branch and then tied up, or to be used as a binding part if the ring surface is formed to prevent slipping. Needless to say, collagen must be adhered and fixed to the surface.
本発明の人工気管を従来のシリコンチューブによるもの
と比較したところ、後者のものはサイズ16IIII1
1、長さ40mmに構成したものを雑種成犬2頭の頚部
気管を6気管輪切除したところへ連続縫合して移植し、
1力月毎に内視鏡観察したところ、2力月目から内腔へ
の肉芽形成、潰瘍形成、支持力不足による変形が見られ
るようになった。4力月目では肉芽形成割合が多くなり
、人工気管としては良い結果が得られなかった。When the artificial trachea of the present invention was compared with one using a conventional silicone tube, the latter was found to be of size 16III1.
1. A device configured with a length of 40 mm was successively sutured and transplanted to the cervical trachea of two adult mongrel dogs where 6 tracheal rings had been removed.
Endoscopic observation was performed every month, and from the second month onwards, granulation formation in the lumen, ulcer formation, and deformation due to lack of support force were observed. At the fourth month, the granulation rate increased, and good results could not be obtained as an artificial trachea.
一方、移植後6力月以上経過した本発明に係るものには
何ら異常が認められなかった。On the other hand, no abnormality was observed in the cells according to the present invention that had passed for 6 months or more after transplantation.
本発明の人工管腔臓器は人工食道として構成することも
できる。この場合には内面を鏡面仕上げした後、上述し
た人工気管の場合と同様にしてコラーゲン層を基体表面
に付着固定する。本発明の人工食道と従来のシリコンラ
バー管によるものとを家兎の食道に用いて比較したとこ
ろ、後者のものは3週間後に脱落したが本発明のものは
6力月経過後も何ら異常なく生体組織とマツチングして
いた。The artificial luminal organ of the present invention can also be configured as an artificial esophagus. In this case, after mirror-finishing the inner surface, a collagen layer is adhered and fixed to the base surface in the same manner as in the case of the artificial trachea described above. When the artificial esophagus of the present invention and the conventional silicone rubber tube were compared in the esophagus of a rabbit, the latter fell off after 3 weeks, but the artificial esophagus of the present invention showed no abnormality even after 6 months. It matched with living tissue.
本発明は上述した実施例にのみ限定されるものではなく
、幾多の変形が可能である。例えば基体の素材、コラー
ゲン付着前の基体表面構成は適宜行なえばよいまたガラ
スセラミックスは熱処理によりリン酸カルシウムを析出
するものとする必要はない。さらにリン酸カルシウム層
の上にβ−702層を被着したが、これも必ずしも必要
ではない。The present invention is not limited to the embodiments described above, but can be modified in many ways. For example, the material of the substrate and the surface structure of the substrate before collagen attachment may be appropriately selected, and the glass ceramics need not be heat-treated to precipitate calcium phosphate. Additionally, a β-702 layer was deposited on top of the calcium phosphate layer, but this is also not necessary.
以上のごとく本発明によれば、人工管腔臓器の基体表面
をβ−TCPやハイドロキシアパタイトなとのリン酸カ
ルシウム系材料で形成したことにより組織親和性を飛躍
的に向上することができる。As described above, according to the present invention, the tissue affinity can be dramatically improved by forming the base surface of the artificial hollow organ from a calcium phosphate material such as β-TCP or hydroxyapatite.
更にその上をコラーゲン繊維で被覆したことによ ゛り
抗原抗体反応を示さず生体との安定化が実現できた。ま
た基体をガラスセラミックスで形成することにより、気
密性が得られるとともに金属と同様の加工性があり、さ
らに数百度以上で乾熱滅菌できることとなった。Furthermore, by coating the top with collagen fibers, we were able to achieve stability with living organisms without causing antigen-antibody reactions. Furthermore, by forming the base body from glass ceramics, it is not only airtight, but also has workability similar to that of metal, and can be dry heat sterilized at temperatures of several hundred degrees or higher.
第1図は本発明の人工気管の実施例を示す全体図、
第2図〜第6図は同じくその製造工程を示す図、第7図
は基体表面構成を示す拡大断面図である。
1・・・人工気管
2・・・ガラスセラミックス本体(基体)3・・・アパ
タイト結晶層(基体)
4・・・β−702層(基体)
5・・・コラーゲン層
特許出潮人 オリンパス光学工業株式会社手 続
補 正 書
昭和63年 1月 9日
特許庁長官 小 川 邦 夫 殿1、事
件の表示
昭和62年特許願第268124号
2、発明の名称
人工管腔臓器
3、補正をする者
事件との関係 特許出願人
(037) オリンパス光学工業株式会社4、代理人
5、補正の対象
1、明細書第3頁第3行の「安定かすることが」を「安
定化することが」に訂正する。
2、同第5頁第17行の「人工管1」を「人工気管1」
に訂正する。
3、同第6頁第10行の「中間部26」を「中間部2a
」に訂正する。
4、同第8頁第19行の「行なえばよいまた」を「行な
えばよい。また」に訂正する。FIG. 1 is an overall view showing an embodiment of the artificial trachea of the present invention, FIGS. 2 to 6 are views showing the manufacturing process thereof, and FIG. 7 is an enlarged sectional view showing the surface structure of the base body. 1...Artificial trachea 2...Glass ceramic body (substrate) 3...Apatite crystal layer (substrate) 4...β-702 layer (substrate) 5...Collagen layer Patented Izushiojin Olympus Optical Industry Co., Ltd. Procedures Amendment Book January 9, 1986 Director General of the Patent Office Kunio Ogawa 1. Indication of the case 1988 Patent Application No. 268124 2. Name of the invention Artificial luminal organ 3. Person making the amendment Relationship to the case Patent applicant (037) Olympus Optical Industry Co., Ltd. 4, Agent 5, Subject of amendment 1, “Stabilizing” on page 3, line 3 of the specification is “stabilizing” Correct to. 2. "Artificial tube 1" on page 5, line 17 of the same page is replaced with "artificial trachea 1."
Correct to. 3. Change "middle part 26" on page 6, line 10 to "middle part 2a".
” is corrected. 4. In the 19th line of page 8, correct the phrase "you should do it again" to "you should do it again."
Claims (1)
の外表面に繊維コラーゲンを被覆したことを特徴とする
人工管腔臓器。 2、前記基体がリン酸カルシウム形材料を含むことを特
徴とする特許請求の範囲第1項記載の人工管腔臓器。[Scope of Claims] 1. An artificial hollow organ characterized in that the outer surface of a tubular base body made of a dense material having tissue affinity is coated with fibrous collagen. 2. The artificial hollow organ according to claim 1, wherein the base body contains a calcium phosphate type material.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP62268124A JPH01110366A (en) | 1987-10-26 | 1987-10-26 | Artificial tubal organ |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP62268124A JPH01110366A (en) | 1987-10-26 | 1987-10-26 | Artificial tubal organ |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH01110366A true JPH01110366A (en) | 1989-04-27 |
Family
ID=17454217
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP62268124A Pending JPH01110366A (en) | 1987-10-26 | 1987-10-26 | Artificial tubal organ |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH01110366A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5413597A (en) * | 1990-12-29 | 1995-05-09 | Krajicek; Milan | Three-layer vascular prostheses |
| WO1998022156A1 (en) * | 1996-11-20 | 1998-05-28 | Tapic International Co., Ltd. | Artificial esophagus |
| EP0968729A3 (en) * | 1998-07-03 | 2000-01-12 | Jin-Yong Lee | Bone regeneration material |
-
1987
- 1987-10-26 JP JP62268124A patent/JPH01110366A/en active Pending
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5413597A (en) * | 1990-12-29 | 1995-05-09 | Krajicek; Milan | Three-layer vascular prostheses |
| WO1998022156A1 (en) * | 1996-11-20 | 1998-05-28 | Tapic International Co., Ltd. | Artificial esophagus |
| US6241774B1 (en) | 1996-11-20 | 2001-06-05 | Yasuhiko Shimizu | Artificial esophagus |
| EP0968729A3 (en) * | 1998-07-03 | 2000-01-12 | Jin-Yong Lee | Bone regeneration material |
| US6406711B1 (en) | 1998-07-03 | 2002-06-18 | Jin-Yong Lee | Bone regeneration material |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3588920A (en) | Surgical vascular prostheses formed of polyester fiber paper | |
| de Groot | Clinical applications of calcium phosphate biomaterials: a review | |
| Zafar et al. | Bioactive surface coatings for enhancing osseointegration of dental implants | |
| Neacşu et al. | Inorganic micro-and nanostructured implants for tissue engineering | |
| De Groot | Bioceramics consisting of calcium phosphate salts | |
| Bermax | The experimental replacement of portions of the esophagus by a plastic tube | |
| Hanel et al. | Current PTFE grafts: a biomechanical, scanning electron, and light microscopic evaluation | |
| US20060134160A1 (en) | Calcium phosphate coated implantable medical devices and processes for making same | |
| US20250144273A1 (en) | Bioimplant | |
| JP6289708B2 (en) | Biological implant | |
| JPH01299549A (en) | Artificial bone structure for bone implantation | |
| JP5891150B2 (en) | Method for producing dental implant | |
| JP4916159B2 (en) | Biological duct stent | |
| Regi et al. | Degradative effects of the biological environment on ceramic biomaterials | |
| JPH01110366A (en) | Artificial tubal organ | |
| Kim et al. | Octacalcium phosphate, a promising bone substitute material: a narrative review | |
| CN100536799C (en) | Animal Tissue Growth Inducing Scaffold | |
| Naik | Advanced bioceramics | |
| White et al. | Preliminary report: Evaluation of tissue ingrowth into experimental Replamineform vascular prostheses | |
| JPH04506765A (en) | tubular organ prosthesis | |
| CN111481744A (en) | Bone defect artificial prosthesis | |
| CN210186109U (en) | Bone defect artificial prosthesis | |
| CN1080627A (en) | Biological active incline ceramic material | |
| JPH05317408A (en) | Artificial blood vessel | |
| Debry et al. | Biomaterials in laryngotracheal surgery: a solvable problem in the near future? |